Adapthealth ( (AHCO) ) has released its Q3 earnings. Here is a breakdown of the information Adapthealth presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AdaptHealth Corp., a prominent player in the healthcare-at-home sector, specializes in providing home medical equipment, supplies, and related services across the United States. The company operates through four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.3 million patients annually.
In its third quarter of 2025, AdaptHealth reported a slight increase in net revenue to $820.3 million, marking a 1.8% rise compared to the same period in 2024. The company also achieved significant milestones, including signing a new capitated agreement and expanding its digital patient engagement platform, which saw a substantial increase in registered users.
Key financial highlights from the quarter include a net income of $24.5 million, up from $22.9 million in the previous year, and an adjusted EBITDA of $170.1 million, reflecting a 3.5% increase. The company also successfully reduced its debt by $50 million, contributing to a year-to-date debt reduction of $225 million, aligning closely with its net leverage target.
Despite a decrease in free cash flow year-to-date compared to 2024, the company’s cash flow from operations improved, reaching $418.6 million. AdaptHealth’s strategic focus on operational improvements and sustainable growth was emphasized by CEO Suzanne Foster, highlighting the company’s progress and future opportunities.
Looking ahead, AdaptHealth maintains its financial guidance for 2025, projecting net revenue between $3.18 billion and $3.26 billion and adjusted EBITDA ranging from $642 million to $682 million. The company remains committed to building foundational capabilities to drive long-term growth.